JM, Z., AD, S., A, M., WF, M., & S, P. (2019). Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: Results of a phase III clinical trial (FORWARD-3). Dove Medical Press.
Cita Chicago Style (17a ed.)JM, Zajecka, Stanford AD, Memisoglu A, Martin WF, y Pathak S. Buprenorphine/samidorphan Combination for the Adjunctive Treatment of Major Depressive Disorder: Results of a Phase III Clinical Trial (FORWARD-3). Dove Medical Press, 2019.
Cita MLA (8a ed.)JM, Zajecka, et al. Buprenorphine/samidorphan Combination for the Adjunctive Treatment of Major Depressive Disorder: Results of a Phase III Clinical Trial (FORWARD-3). Dove Medical Press, 2019.
Precaución: Estas citas no son 100% exactas.